Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Immunodeficiency”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04944979
What this trial is testing

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)

Who this might be right for
Primary Immunodeficiency Disease
Kedrion S.p.A. 30
Not applicableUnknownNCT02082353
What this trial is testing

Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995

Who this might be right for
Granulomatous Disease, Chronic
National Institute of Allergy and Infectious Diseases (NIAID) 1,480
Early research (Phase 1)Study completedNCT00001765
What this trial is testing

Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 60
Very early researchActive Not RecruitingNCT03910452
What this trial is testing

Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 4
Not applicableAvailableNCT07216378
What this trial is testing

Treatment of Angioedema Attacks in Pediatric (Ages 2-11) Post-Trial and Naive Patients With HAE With Sebetralstat

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd.
Not applicableEnded earlyNCT02246491
What this trial is testing

Cell-Based Approaches For Modeling and Treating Ataxia-Telangiectasia

Who this might be right for
Ataxia-Telangiectasia (A-T)
Johns Hopkins University 6
Early research (Phase 1)Study completedNCT00002096
What this trial is testing

A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Hoffmann-La Roche 24
Testing effectiveness (Phase 2)Ended earlyNCT02512679
What this trial is testing

Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells

Who this might be right for
Stem Cell TransplantationBone Marrow TransplantationPeripheral Blood Stem Cell Transplantation+10 more
Children's Hospital Los Angeles 20
Testing effectiveness (Phase 2)Study completedNCT00001061
What this trial is testing

Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 167
Not applicableUnknownNCT04897113
What this trial is testing

Study of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old

Who this might be right for
HypercholesterolemiaHyperbilirubinemiaHyper IgE Syndrome+9 more
National Medical Research Center for Rehabilitation and Balneology 80
Not applicableActive Not RecruitingNCT05321407
What this trial is testing

COVID-19 Vaccine Responses in PIDD Subjects

Who this might be right for
X-linked AgammaglobulinemiaXLAPrimary Immune Deficiency+4 more
Duke University 100
Not applicableLooking for participantsNCT07293364
What this trial is testing

Learn About the C1-Inhibitor Function as Diagnosis for Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 514
Testing effectiveness (Phase 2)Study completedNCT01095497
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration

Who this might be right for
Hereditary Angioedema
Shire 26
Not applicableStudy completedNCT02244450
What this trial is testing

Generalized Neonatal Screening of Severe Combined Immunodeficiencies

Who this might be right for
Severe Combined Immunodeficiency, Atypical
Nantes University Hospital 190,539
Post-approval studies (Phase 4)UnknownNCT05070455
What this trial is testing

An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)

Who this might be right for
Primary Immune Deficiency
ADMA Biologics, Inc. 12
Not applicableStudy completedNCT00852943
What this trial is testing

Screening Protocol for Genetic Diseases of Allergic Inflammation

Who this might be right for
Eosinophilic DiseaseImmune DeficiencyHaTS+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 834
Post-approval studies (Phase 4)Study completedNCT00634569
What this trial is testing

Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects

Who this might be right for
Primary Immune Deficiency Disease
Instituto Grifols, S.A. 24
Not applicableUnknownNCT02231983
What this trial is testing

Clinical Characteristics and Genetic Profiles of Severe Combined Immunodeficiency in China

Who this might be right for
Severe Combined Immunodeficiency
Shanghai Children's Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT01359969
What this trial is testing

Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients

Who this might be right for
Hereditary Angioedema
Pharming Technologies B.V. 57
Large-scale testing (Phase 3)Study completedNCT01199705
What this trial is testing

Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

Who this might be right for
Primary Immune Deficiency
CSL Behring 25
Next Page